General New alpha-emitting radiopharmaceutical therapy achieves strong responses in advanced prostate cancerBy Healthcare Propulsion StaffOctober 26, 20260 A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting toxicities observed, and showed…
